Organization:Institute for Safe Medication Practices

From HandWiki
Institute for Safe Medication Practices
Type501(c)(3) nonprofit organization
FounderMichael R. Cohen

The Institute for Safe Medication Practices (ISMP) is an American 501(c)(3) organization focusing on the prevention of medication errors and promoting safe medication practices.[1] It is affiliated with ECRI.[2]

Activities

Among others, ISMP maintains and disseminates a list of "do not crush" medications,[3] as well as clinical best practices.[4] The ISMP's Medication Safety Self-Assessment tool has been used in surveys of medication safety in hospitals in the United States and elsewhere.[5][6][7][8]

The ISMP frequently investigates and reports on medication errors that have occurred in practice. These investigations are often published in the peer-reviewed journal Hospital Pharmacy.[9][10][11]

References

  1. ↑ Guidestar. "Institute for Safe Medication Practices". https://www.guidestar.org/profile/23-2757559. 
  2. ↑ ECRI. "ECRI and the Institute for Safe Medication Practices (ISMP) Launch New Patient Safety Organization". www.prnewswire.com (Press release). Retrieved 2021-06-30.
  3. ↑ Cohen, Michael R. (July 2007). ""Do Not Crush" list" (in en-US). Nursing2021 37 (7): 12. doi:10.1097/01.NURSE.0000279404.54880.3a. ISSN 0360-4039. https://dx.doi.org/10.1097/01.NURSE.0000279404.54880.3a. 
  4. ↑ "ISMP Publishes 2020-2021 Consensus-Based Medication Safety Best Practices for Hospitals" (in en). 27 February 2020. https://www.ismp.org/news/ismp-publishes-2020-2021-consensus-based-medication-safety-best-practices-hospitals. 
  5. ↑ Lesar, Timothy; Mattis, Arnold; Anderson, Ernest; Avery, Jean; Fields, John; Gregoire, Jill; Vaida, Allen; VHA New England Medication Error Prevention Initiative Collaborative (2003-05-01). "Using the ISMP Medication Safety Self-Assessment™ to Improve Medication Use Processes" (in en). The Joint Commission Journal on Quality and Safety 29 (5): 211–226. doi:10.1016/S1549-3741(03)29026-2. ISSN 1549-3741. PMID 12751302. https://www.sciencedirect.com/science/article/abs/pii/S1549374103290262. 
  6. ↑ Vaida, Allen J.; Lamis, Rebecca L.; Smetzer, Judy L.; Kenward, Kevin; Cohen, Michael R. (2014-02-01). "Assessing the State of Safe Medication Practices Using the ISMP Medication Safety Self Assessment® for Hospitals: 2000 and 2011" (in en). The Joint Commission Journal on Quality and Patient Safety 40 (2): 51–AP3. doi:10.1016/S1553-7250(14)40007-2. ISSN 1553-7250. PMID 24716328. https://www.sciencedirect.com/science/article/abs/pii/S1553725014400072. 
  7. ↑ Greenall, Julie; Shastay, Ann; Vaida, Allen J; U, David; Johnson, Philip E; O’Leary, Joe; Chambers, Carole (2015-02-01). "Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology" (in en). Journal of Oncology Pharmacy Practice 21 (1): 26–35. doi:10.1177/1078155214556522. ISSN 1078-1552. PMID 25361598. https://doi.org/10.1177/1078155214556522. 
  8. ↑ McCarthy, Kaitlyn R.; Christakos, Eugenia; Kurzatkowski, Amy; Gernant, Stephanie A. (2021-07-01). "Characterizing perceptions of an abbreviated ISMP Medication Safety Self Assessment for community pharmacies" (in en). Journal of the American Pharmacists Association 61 (4): S105–S117. doi:10.1016/j.japh.2021.02.013. ISSN 1544-3191. PMID 33812781. 
  9. ↑ Mancano, Michael A.; Esordi, Morgan V.; Patel, Darshil D.; Milenki, Kristen J. (2019-04-01). "ISMP Adverse Drug Reactions: Longitudinal Thumbnail Fissures Due to Erlotinib Priapism Associated With the Use of ExtenZe Blindness From a Nevirapine-Based HAART Regimen Hyperprolactinemia and Galactorrhea Due to Aripiprazole Trypophobia Associated With Gabapentin Coadministered Linezolid and Methadone Cause Serotonin Syndrome" (in en). Hospital Pharmacy 54 (2): 88–92. doi:10.1177/0018578718824449. ISSN 0018-5787. PMID 30923400. PMC 6431722. https://doi.org/10.1177/0018578718824449. 
  10. ↑ Mancano, Michael A. (2018-02-01). "ISMP Adverse Drug Reactions: Influenza Vaccine–Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption" (in en). Hospital Pharmacy 53 (1): 15–17. doi:10.1177/0018578717739727. ISSN 0018-5787. PMID 29434381. PMC 5805017. https://doi.org/10.1177/0018578717739727. 
  11. ↑ Mancano, Michael A.; Lapin, Jonathan; Paik, Andrew (2019-08-01). "ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes" (in en). Hospital Pharmacy 54 (4): 241–245. doi:10.1177/0018578719828860. ISSN 0018-5787. PMID 31320773. PMC 6628555. https://doi.org/10.1177/0018578719828860. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Organization:Institute_for_Safe_Medication_Practices&oldid=3392424"